Activity

In this work, a visible-light-driven photoelectrochemical (PEC) sensing platform was developed based on BiOI nanoflowers/TiO2 nanotubes (BiOI NFs/TiO2 NTs) for detection of atrazine (ATZ). The BiOI NFs/TiO2 NTs p-n heterojunctions synthesized by decorating BiOI NFs on TiO2 NTs via simple hydrothermal approach exhibit strong visible-light absorption ability, high photocurrent response and PEC activity. Thus BiOI NFs/TiO2 NTs heterostructures were first explored to act as the photoelectrode for the immobilization of the anti-ATZ aptamer to develop a PEC sensing platform. The design PEC aptasensing platform exhibits prominent analytical performance for determination of ATZ with a low detection limit of 0.5 pM under visible-light irradiation, and displays good selectivity for ATZ in the control experiments. The superior behavior of the sensing platform could be ascribed to the design of the appropriate sensing material with tubular microstructure, excellent PEC response of the photoelectrode, and the large loading amount of aptamer. Meanwhile, the PEC sensing platform was used to determine ATZ in environmental samples and a satisfied result was obtained.

The study aimed to examine the association between levels of self-reported happiness and different domains and subdomains of negative symptoms (NS), as well as symptomatic remission in schizophrenia.

274 individuals with schizophrenia were assessed on the Subjective Happiness Scale (SHS), Positive and Negative Syndrome Scale and Clinical Assessment Interview for Negative Symptoms (CAINS). Multiple linear regressions were used to examine the association between levels of happiness and increasingly specific CAINS NS domains and subdomains, as well as symptomatic remission.

177 (64.6%) participants rated themselves as happy. NS, specifically motivation and pleasure related to social activities (MAP Social) (B=-0.402, t=-4.805, p<0.001), and depressive symptoms (B=-0.760, t=-7.102, p<0.001) were significantly associated with levels of happiness. Individuals in symptomatic remission rated themselves happier than those who were not in remission (mean composite SHS 5.10 [SD=1.18] versus 4.61 [SD=1.16], p=0.002).

In this largest study on happiness in schizophrenia, we found that the MAP domain of NS, MAP social subdomain and depressive symptoms were significantly associated with levels of happiness. Additionally, individuals in symptomatic remission rated themselves happier than those who were not in remission. Symptom management remains important in the holistic care plan for individuals with schizophrenia.

In this largest study on happiness in schizophrenia, we found that the MAP domain of NS, MAP social subdomain and depressive symptoms were significantly associated with levels of happiness. Additionally, individuals in symptomatic remission rated themselves happier than those who were not in remission. Symptom management remains important in the holistic care plan for individuals with schizophrenia.The catalyst activity of the nano Au was largely dependent on the particle size and the structure of the supported matrix to avoid particle agglomeration. Chitosan (CS) and CS coated layered double hydroxide of NiAl (LDH) microsphere were designed through a simple and an economic casting method. The CS and LDH microsphere were used for the impregnation and support of Au NPs and represented as Au/CS and Au/LDH and used for the sole and concurrent discoloration of methylene blue (MB) and rhodamine B (RB) dyes. The aim of the incorporation of NiAl-LDH to the CS host polymer is to increase the binding capacity of CS with Au NPs to make it more stable. The Au/LDH displaying stronger catalyst activity for both dyes discoloration, while found highly selective for MB dye. The high catalyst activity of Au/LDH is due to their small crystallite size which is 1.02 nm compared to 6.75 nm in Au/CS derived from Scherer’s equation. The kapp value based on zero-order kinetics was higher with Au/LDH against MB and RB dyes which are 3.5 × 10-1 and 1.4 × 10-1 min-1 respectively.Recently, bioaccumulation of dietary organic selenium (Se) in the ovaries and inhibition of reproduction in female aquatic animals have been reported. However, there is limited data on the subtle reproductive impacts of waterborne exposure to inorganic Se in fish. Here, zebrafish embryos (2 h post-fertilization) were exposed to solutions with environmentally relevant levels of Na2SeO3 with concentrations of 0 (control), 7.98 ± 0.31, 25.14 ± 0.15, and 79.60 ± 0.81 μg Se/L for 120 d until they reached sexual maturity. Female zebrafish were selected for reproductive toxicity assessment. In the early embryonic stage, whole-mount in situ hybridization of zebrafish embryos showed that waterborne Na2SeO3 exposure did not affect the observed location of vasa expression in primordial germ cells at 24, 48, and 72 h post-fertilization. Life-cycle exposure to 25.14 ± 0.15 and 79.60 ± 0.81 μg Se/L Na2SeO3 did not change the testosterone and 17β-estradiol contents in female zebrafish at the endpoint of exposure, but significantly reduced the proportion of early vitellogenic oocytes and mature oocytes. Follicle maturity retardation was accompanied by changes in transcriptional levels of the genes related to the hypothalamus-pituitary-gonad-liver (HPGL) axis. Transcriptional levels of cyp19a and lhr in the ovary were down-regulated, while the transcriptional level of fshr in the ovaries was up-regulated. In the 21-day cumulative spawning experiment, Na2SeO3 (25.14 ± 0.15 and 79.60 ± 0.81 μg Se/L) caused fewer eggs to be produced. Additionally, the malformation of zebrafish offspring significantly increased in the group exposed to 79.60 ± 0.81 μg Se/L. In conclusion, for the first time, this study shows that life-cycle exposure to environmentally relevant concentrations of waterborne Na2SeO3 significantly delays ovarian maturation and reduces the fertility of the female zebrafish.

Increasing drug prices strains budgets. Assessing the relation between added benefit and prices can help clinical decision-making and resource allocation.

We assessed, over a period of 13 years, the relation between added therapeutic benefit and prices for drugs to treat solid tumours in France using the French High Authority of Health Scale (ASMR) and the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (MCBS).

In total, 36 medications were approved for 68 indications. There was a weak correlation between ASMR and MCBS scales (Spearman’s |ρ|=0.28). Drugs had low added benefit on both ASMR (71%) and MCBS (49%). K-Ras(G12C) inhibitor 12 Mean monthly price for new drugs was €4616 (S.D., €3096), ranging from €1795 to €19,675 and increased by 47% comparing 2004-2012 with 2013-2017. The mean monthly price difference of new drugs over their comparator was €3700 (S.D., €3934) ranging between a €13,853 decrease and a €19,675 increase. There was a weak but statistically significant correlation between ASMR and price (|ρ|=0.